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Abstract New sequencing technologies have ushered in a
new era for diagnosis and discovery of new causative
mutations for rare diseases. However, the sheer numbers of
candidate variants that require interpretation in an exome
or genomic analysis are still a challenging prospect. A
powerful approach is the comparison of the patient’s set of
phenotypes (phenotypic profile) to known phenotypic
profiles caused by mutations in orthologous genes associ-
ated with these variants. The most abundant source of
relevant data for this task is available through the efforts of
the Mouse Genome Informatics group and the International
Mouse Phenotyping Consortium. In this review, we high-
light the challenges in comparing human clinical pheno-
types with mouse phenotypes and some of the solutions
that have been developed by members of the Monarch
Initiative. These tools allow the identification of mouse
models for known disease-gene associations that may
otherwise have been overlooked as well as candidate genes
may be prioritized for novel associations. The culmination
of these efforts is the Exomiser software package that
allows clinical researchers to analyse patient exomes in the
context of variant frequency and predicted pathogenicity as
well the phenotypic similarity of the patient to any given
candidate orthologous gene.
Introduction
Despite the many recent successes in identifying causative
mutations for human heritable diseases through the use of
new sequencing technologies, an associated gene has not
been identified for approximately half of the *7000 dis-
eases (Boycott et al. 2013) with current progress at
150–200 new disease-gene identifications per year (http://
www.irdirc.org). Discovery of these genotype-to-pheno-
type relationships is the critical first step towards under-
standing the mechanism of these heritable diseases and
developing potential new treatments.
Although new technologies such as whole exome
sequencing (WES) are cost effective and fast, they typi-
cally generate thousands of potential candidate variations
that need to be interpreted in light of what is known or can
be predicted about the variant and the affected gene. One of
the most powerful lines of evidence comes from whether
the patient’s clinical signs and symptoms show similarity
to phenotype data previously associated with mutations in
the gene.
A wealth of data for this task is available in the Mouse
Genome Database (MGD) (Eppig et al. 2015) through the
curation efforts of the Mouse Genome Informatics (MGI)
group and from the high throughput phenotyping of the
International Mouse Phenotyping Consortium (IMPC)
(Koscielny et al. 2014). The paper by Meehan et al. in this
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issue describes how IMPC aims to complete the functional
catalogue of all protein-coding genes by 2020, strength-
ening the existing status of the mouse as the premier model
organism for investigating human disease.
The MGI and IMPC website resources are available to
clinical researchers to assess individual human disease
variant candidates. However, until recently this data have
been under-utilized and not used in an automated, sys-
tematic approach due to the challenges in comparing
human and mouse phenotypes and the lack of tools
allowing clinicians and researchers to perform these com-
parisons (Gkoutos et al. 2012). In this review, we discuss
the challenges in comparing phenotypes across species and
integration with exome analysis, some of the solutions that
have been developed in the context of the Monarch Ini-
tiative (www.monarchinitiative.org), and emerging tools
for rare disease exome analysis that exploit these
comparisons.
Clinical and model organism phenotype data
Data on the *7000 known genetic and other rare human
diseases are stored in the Online Inheritance in Man
(OMIM) (Amberger et al. 2015). OMIM contains sub-
stantial amounts of descriptive data on the objective signs
and subjective symptoms for each disease. However, as this
data are represented as free text, it is less amenable to
computational analysis, e.g. related diseases cannot easily
be discovered using these descriptions. The Human
Phenotype Ontology (HP) was developed to describe such
phenotypes in a standardized manner that allows such
analyses (Ko¨hler et al. 2014a) and there are now over
11,000 terms in HP. The results of an ongoing curation
effort by the Monarch Initiative, and members of the rare
disease community such as Orphanet (Ayme 2003), are
made publicly available from http://www.human-pheno
type-ontology.org and currently contain annotations for
9019 DECIPHER, OMIM, and Orphanet disorders.
The largest source of mouse phenotype data is the
MGD, containing curated annotation of mouse mutants
described in literature and also by the import of large-scale
projects such as IMPC. Phenotypes are described using the
well-established Mammalian Phenotype Ontology (MP)
developed precisely for this curation effort. MP currently
contains 10,000 terms (Smith and Eppig 2012). MGD
contains 278,701 phenotype annotations for over 53,000
different mouse strains involving disruptions in 10,753
genes. The IMPC database contains data for 1470 strains,
each with a presumptive null mutation in a unique gene,
and 5725 phenotype annotations. The IMPC pipeline
involves a sequential set of tests collecting data on
parameters covering all major adult organs and most major
disease areas (Koscielny et al. 2014). Given the focussed
nature of most published studies, phenotypes that are not
assigned to a MGD strain cannot be assumed to be absent.
In contrast, for the standardized IMPC pipeline, every
assayed phenotype can be assumed to be negative if not
reported. However, the pipeline only covers a defined but
limited range of phenotypes.
At present some 3400 human genes have HP annotations
assigned to them based on their association with disease(s).
Mouse mutants involves only a single gene disruption and
MP annotation(s) exist for 9974 genes, with only 2341
overlapping with the set of human disease genes. Therefore
there is an abundance of genes with genotype–phenotype
information available only in the mouse and potentially
translatable to human disease studies.
The Monarch Initiative (www.monarchinitiative.org) is
an international consortium that aims to integrate data from
a large number of diverse resources for human and model
organisms (including from IMPC, MGD, OMIM, Orpha-
net, etc.) describing diseases, phenotypes, environmental
factors, drugs, literature, research resources, etc. for the
purposes of disease mechanism discovery and diagnosis.
The foundation of the Monarch Initiative is the semantic
integration of genotype–phenotype data into a single
knowledge base that provisions for the application of
graph-based computational analyses through the OWLSim
software package, including phenotypic profile matching
(Washington et al. 2009). Flexible tools for data access and
retrieval through APIs and Web widgets suitable for
inclusion in third-party sites support the customization and
use of this data for diverse purposes.
Cross-species phenotype mapping
The biggest barrier to computational use of the mouse
genotype–phenotype associations for human disease
research is the use of different phenotype ontologies by the
two communities. For example a computer, or even a non-
specialist researcher, would not know that the HP term
craniosynostosis (HP:0001363) is equivalent to the MP
term premature suture closure (MP:0000081). Mungall
et al. 2010 described a process called ‘‘logical decompo-
sition’’ that could be used to define the species-specific
phenotype terms using generic, species-agnostic ontologies
to computationally define the terms in the species-specific
ontologies. Each term is broken down to a combination of a
quality (Q), representing what is abnormal about the entity,
and an entity (E), representing the anatomical structure or
biological process (Ko¨hler et al. 2013; Washington et al.
2009). The entity terms come from well-established
ontologies such as the Gene Ontology (GO 2015), the
Chemical Entities of Biological Interest [CHEBI; (Hastings
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et al. 2013)] ontology, or the UBERON multi-species
anatomy ontology (Mungall et al. 2012; Haendel et al.
2014). The Phenotype and Trait Ontology (PATO) is used
for the qualities. In the above example, both the HP and
MP terms are represented by the premature closure
(PATO:0002166) of the suture (UBERON:0000969) and
therefore can be detected as equivalent by an algorithm. In
this manner, the logic underlying HP and MP is being co-
developed by members of the Monarch Initiative and MGI.
This approach has been applied to human disease,
mouse, and zebrafish datasets. Known disease genes were
detected with high specificity and sensitivity by semantic
phenotype comparisons (Ko¨hler et al. 2013; Washington
et al. 2009). The algorithm performs pairwise comparisons
between each disease and animal phenotype. Related but
non-exact matches can be detected by taking advantage of
the hierarchical structure of the ontologies; e.g. a clinical
phenotype of speech articulation problems and a mouse
mutant exhibiting abnormal larynx morphology would
share a common phenotype of abnormality of the larynx.
Each match is scored using measures of semantic similarity
(Pesquita et al. 2009) such as the Jaccard index or the
Information Content of the common phenotype match. The
similarity between the disease and animal model is then
given by an aggregated score between all the matches, such
as the average score across all possible matches or the
score of the best pairwise match.
Tools for exploring mouse models of human
disease
A number of resources have taken advantage of the cross-
species phenotype matching approach to develop websites
to generate a ranked list of mouse models for a chosen
human disease (Chen et al. 2012; Hoehndorf et al. 2011;
Smedley et al. 2013). Here we will describe the features
available in some of the various tools developed by
members of the Monarch Initiative before describing the
Monarch Initiative website itself that integrates data from
many other sources and allows users to visualize the phe-
notypic similarities.
PhenoDigm
PhenoDigm allows users to query for copy number variant
(CNV) syndromes from DECIPHER (Bragin et al. 2014) as
well as rare diseases from OMIM and Orphanet. Ranked
results from mouse and zebrafish phenotype comparisons
are displayed along with the information on whether the
mutation in the gene is known to be associated with the
disease or is located in a critical region for diseases not yet
associated with any gene. Clicking on a gene presents the
results from individual animal models associated with that
gene so the affect of different alleles, zygosity, and genetic
background can be compared to select the optimal model.
Many of these mouse models can then be ordered from
public repositories for hypothesis-driven mechanistic or
therapeutic target validation or purpose-driven therapeutic
target effect experiments, e.g. the European Mouse Mutant
Archive (Wilkinson et al. 2010). The individual matched
phenotypes for each model can also be explored. Figure 1
shows an example where a disease (Craniosynostosis, type
1 OMIM:123100) associated with mutations of TWIST1 is
queried to discover that suitable Twist1 mouse models of
this disease exist and are available in public repositories.
These tools can also be used to suggest candidate disease
genes for diseases with no known molecular association.
PhenogramViz
The cross-species phenotype comparison approach can also
be used to assess the contribution of multiple genes within
CNV regions to the disease phenotype (Doelken et al.
2013). Cases can be seen where the whole CNV syndrome
can be explained by the disruption of only one of the
affected genes, as well as others where different aspects of
the syndrome are linked to different genes. PhenogramViz
is a Cytoscape plug-in that allows clinicians to explore
their own CNV patients by entering the deleted or dupli-
cated region along with patient phenotypes (Ko¨hler et al.
2014b).
International Mouse Phenotyping Consortium
Elsewhere in this issue, Meehan et al. describe the IMPC
standardized phenotyping pipeline and portal. The data
being generated by the IMPC’s controlled and robust sta-
tistical analysis framework are likely to be significantly
more reproducible than literature-reported findings. Here,
the IMPC has also mapped their quantitative assays to the
MP, which enables semantic comparison using the Phe-
noDigm methodology to present high-quality, potential
disease models in the IMPC pages. Rather than simple
searches for results on individual diseases, faceted, com-
binatorial searches are allowed using factors such as dis-
ease category e.g. cardiac, and whether they are associated
with known gene associations or with predicted associa-
tions from cross-species phenotype comparisons. Figure 2
shows an example where a novel candidate (ARHGEF11)
is identified for Cone-Rod dystrophy 8 (OMIM:605549)
based on phenotype matches to the IMPC model and the
location of the gene in a previously identified critical
region.
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The Monarch PhenoGrid
The integrated genotype–phenotype data held within
Monarch can be utilized to drive the identification of
models for disease research and disease diagnostics (as
described above and for Exomiser below). Such integrated
data can also be utilized for visualization of the relation-
ships between the different data types. For example, Phe-
noGrid (Fig. 3), available on the Monarch website,
highlights the phenotypic similarity of patient or disease
profiles against the most similar mouse models. For soft-
ware developers, PhenoGrid is available as an open-source
widget suitable for integration in third-party websites
(www.github.com/monarch-initiative/phenogrid), and is
customizable with respect to organism, genotypes versus
genes, and user-specified comparisons.
Clinical application to rare disease diagnostics
Many incidences of rare disease remain undiagnosed after
exome or genome sequencing due to the sheer number of
candidate variants. Even after removing low quality and
common variants and those deemed unlikely to be
pathogenic, 10–100’s of variants remain. It is already
known that each of us harbour *100 genuine loss of
function variants with *20 genes completely inactivated
(MacArthur et al. 2012), so prioritization based solely on
variant frequency and pathogenicity is unlikely to identify
the causative variant. The additional strategies of studying
multiple-affected individuals, linkage data, identity-by-
descent inference, de novo heterozygous mutations from
trio analysis, or prior knowledge of affected pathways to
narrow down to the causative variant are often not possible
or successful.
In the last few years, a number of tools have been
developed that utilize phenotype data associated with the
patient as well as the results of sequencing (Javed et al.
2014; Robinson et al. 2014; Sifrim et al. 2013; Zemojtel
et al. 2014). One of these tools, Exomiser, uses an algo-
rithm termed PHenotypic Interpretation of Variants in
Exomes (PHIVE) to combine data on the rarity of the
variant and its predicted pathogenicity along with the
similarity of the patient-to-mouse models for each candi-
date gene in the exome. A high scoring variant will be:
(i) rarely or never observed in the 1000 Genomes Project
and Exome Variant Server datasets, (ii) predicted to be
highly pathogenic by PolyPhen, SIFT, and/or
Fig. 1 Cross-species phenotype comparisons using PhenoDigm
identify an animal model for Craniosynostosis, type 1. Craniosynos-
tosis, type 1 (OMIM:123100) is already known to be associated with
mutations in TWIST1 (top panel). The bottom left panel reveals that
mouse mutants of Twist1 represent a good phenotypic match to the
clinical signs of this disease. The bottom right-hand panel shows the
scores and evidence for different mouse mutants involving Twist1,
allowing researchers to follow the Order online link to obtain the
most relevant mouse strain for further mechanistic studies or
therapeutic development
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MutationTaster, and (iii) be located in a gene with a mouse
model that exhibits very similar phenotypes to the patient.
For the phenotype comparisons, PHIVE uses the same
OWLSim methodology used in the tools above and mouse
phenotype data from MGI and IMPC. Benchmarking was
performed on 100,000 simulated disease exomes containing
known disease variants from HGMD added to unaffected
exomes from the 1000 Genomes Project. The variant-based
scores (frequency and pathogenicity) were found to combine
synergistically with the phenotype scores to optimize the
identification of the known causative variant as the top hit.
The correct gene was recalled as the top hit in up to 83 % of
samples and performance was improved by up to 54 fold by
including phenotype information.
Although 88 % of the disease genes assessed had mouse
strains with mutation in the orthologous gene, there were
obviously some tested exomes where mouse phenotype
data were missing and therefore performance will be
expected to improve as the IMPC nears its goal of complete
coverage of the genome. In the mean time, coverage has
been increased by including human and zebrafish pheno-
types as well as a guilt-by-association approach using
protein–protein associations for those genes that have no
data in any of the species. This modified algorithm (hiP-
HIVE) was able to detect the known disease-gene associ-
ations as the top hit in 97 % of the benchmarking exomes.
In a strategy where the known human disease-gene phe-
notypes were masked, representing discovery of a novel
Fig. 2 Identification of a novel candidate for Cone-Rod dystrophy 8
using cross-species phenotype comparisons at the IMPC portal. A
high scoring phenotype match for OMIM:605549 is obtained for an
IMPC mouse strain involving disruption of the mouse Arhgef11 gene
where abnormalities of the retina are reported in both the disease and
the model. In addition, the tool highlights the human orthologue that
lies within the previously reported locus at 1q12-24
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association, the correct variant was detected as the top hit
in 87 % of the benchmarking exomes. This version of
Exomiser is being used by a number of groups as part of
their analysis pipeline, such as the NIH Undiagnosed
Disease Program (Gahl et al. 2012). The downloadable,
command-line version of Exomiser requires no additional
installation steps and is easily integrated into any bioin-
formatic pipeline.
Conclusions
In this review we have highlighted the latest achievements
in the computational analysis of mutations in mouse genes,
mouse phenotypes, and mouse genotype–phenotype asso-
ciations for novel insights into human disease. That any of
this has been possible is testament to the remarkable ability
of mouse models to recapitulate disease phenotypes, and
the advances made in using ontologies to annotate and
query disease and model organism data.
Improvements to the ontologies and algorithms are needed
in particular disease areas (Oellrich et al. 2014; Robinson and
Webber 2014). Beyond these technical challenges, a cultural
shift is still needed to encourage collection of higher-quality
phenotype data. For efficient and accurate diagnosis of rare
disease patients, detailed and comprehensive clinical pheno-
types need to be collected to be used alongside the new
sequencing technologies in analysis (see http://monarch-
initiative.blogspot.com/2015/01/how-to-annotate-patients-phe
notypic.html for further detail). Use of tools such as Pheno-
Tips (Girdea et al. 2013) can greatly facilitate informative
patient phenotyping. On the mouse side, although IMPC will
collect and annotate phenotype data on all protein-coding
genes, the additional published phenotypes on these and other
strains of mice will be vital for the successful interpretation of
human genotype and phenotype data.
The role MGI plays in collecting these extra annotations
will still be critical but the development of journal data
submission rules for phenotypes would also be a welcome
improvement. For example, if authors were required to
describe all negative phenotypes (phenotypes measured but
found to show no significant difference from wild type)
then this highly relevant data could be incorporated into the
phenotype matching algorithms. The Monarch Initiative is
developing an online phenotyping tool to facilitate easy
capture of phenotype data for any model organism and
validate the genotypes with the correct nomenclature
authorities. This will be critical to ensure publication of
sufficient information to adequately link the phenotypic
consequences of mutation to the specific genotype (Vasi-
levsky et al. 2013). The tool will also indicate whether or
not the phenotypic profiles of the models are sufficient for
comparison against all other known models of disease.
Assuming these challenges continue to be addressed,
and with the completion of the IMPC’s dataset on func-
tional consequences of mutation in all genes and the further
Fig. 3 Monarch PhenoGrid showing a phenotypic comparison of
Parkinson’s disease with the most phenotypically similar mouse
models. Matching phenotypes are displayed in rows, matching models
in columns (indicated here by the gene that is mutated), and cell
contents colour coded with greater saturation indicating greater
similarity. Mouse-over tooltips highlight diseases associated with a
selected phenotype (or vice versa), or details (including similarity
scores) of any match between a phenotype and a model. This example
can be seen in the Compare tab at http://monarchinitiative.org/
disease/DOID:14330 (Color figure online)
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development of these computational approaches, the next
few years promise to be an exciting era for furthering our
understanding of human disease by comparison analysis
with mouse models.
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